WA-AMAZON-WEB-SERVICES
23.6.2020 10:11:07 CEST | Business Wire | Press release
Today, Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), and Formula 1 (F1) (NASDAQ: FWONA, FWONK) are introducing six new, real-time racing statistics that will roll out through the 2020 season, beginning with the launch of “Car Performance Scores” at the season opening Grand Prix in Spielberg, Austria July 3-5. “Car Performance Scores” isolate an individual car’s performance and allows race fans to compare its performance to that of different vehicles head-to-head. The new set of statistics to be released this season will use a range of AWS services, including machine learning, to give fans the ability to compare their favorite drivers and cars and better predict race outcomes. Learn more at: https://aws.amazon.com/f1/ .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200623005380/en/
With 300 sensors on each F1 race car generating more than 1.1M data points per second transmitted from the cars to the pit, Formula 1 is a truly data-driven sport where much of the thrill comes from extracting exciting details on performance statistics. F1 relies on the breadth and depth of AWS services to stream, process, and analyze that flood of data in real-time, and then present it in a meaningful way for F1 global TV viewers. The new “Car Performance Scores” insight will display as an on-screen graphic that provides fans with a complete breakdown of a car’s total performance using four core metrics: Low-Speed Cornering, High-Speed Cornering, Straight Line, and Car Handling. The new graphic will illustrate how those metrics compare from one car to another, enabling race fans to gauge a given car’s relative performance in those different areas and see where each team and driver is leading the pack or losing crucial time to their rivals.
F1 and AWS previously announced six F1 Insights, including Exit Speed, Predicted Pit Stop Strategy, Pit Window, Battle Forecast, Pit Strategy Battle, and Tyre Performance and will roll out the following six additional “F1 Insights powered by AWS” stats as on-screen graphics from July through December of this season, offering fans more visibility into the split-second decision-making and action on the track, as well as behind the pit wall where the team strategists operate:
- Car Performance Scores: Isolates an individual car’s performance and allows race fans to compare its performance to that of different vehicles head-to-head (debuts July 3-5 at the FORMULA 1 ROLEX GROSSER PREIS VON ÖSTERREICH GRAND PRIX 2020).
- Ultimate Driver Speed Comparison: Allows race fans to see how their favorite drivers compare to other drivers in history, dating back to 1983, to help determine the fastest driver of all time (debuts August 7-9 at the EMIRATES FORMULA 1 70th ANNIVERSARY GRAND PRIX 2020).
- High-Speed/Low-Speed Corner Performance: Allows fans to see how well drivers tackle the fastest bends on the track travelling at more than 175 kph/109 mph and slow cornering (below 125 kph/78 mph) compared to other vehicles, which is critical to lap time (debuts August 28-30 at the FORMULA 1 ROLEX BELGIAN GRAND PRIX).
- Driver Skills Rating: Breaks down and scores driver skills, based on the most important factors for overall performance, to help identify the best “total driver” on the track. By calculating varying subsets of qualifying round performance, starts, race pace, tire management, and overtaking/defending styles, this insight will provide an overall driver ranking (debuts the second half of the season).
- Car/Team Development & Overall Season Performance: As the season unfolds, this will plot a team’s cumulative performance from race to race to uncover the development rates of each team (debuts the second half of the season).
- Qualifying and Race Pace Predictions: Gather data from practice and qualifying laps to predict which team is poised for success ahead of each race session. These predictions will create heightened intrigue and excitement for the Saturday qualifying session and Sunday race (debuts the second half of the season).
To create these new insights, Formula 1 will use 70 years of historical race data stored in Amazon Simple Storage Service (Amazon S3), combined with live data that is streamed from sensors on F1 race cars and the trackside to the cloud through Amazon Kinesis, a service for real-time data collection, processing, and analysis. F1 engineers and scientists will use this data to leverage machine learning (ML) models with Amazon SageMaker, AWS’s service for building, training, and deploying ML models. F1 is able to analyze race performance metrics in real-time by deploying those ML models on AWS Lambda, which runs code without the need to provision or manage servers. All of the insights will be integrated into the international broadcast feed of F1 races around the globe, including its digital platform F1.tv, helping fans to understand the split-second decisions and race strategies made by drivers or team strategists that can dramatically affect a race outcome.
“Over the past two years, Formula 1 has embraced AWS’s services to perform intense and dynamic data analysis. The F1 Insights we’re delivering together are bringing fans closer to the track than ever before, and unlocking previously untold stories and insights from behind the pit wall,” said Rob Smedley, Chief Engineer of Formula 1. “We’re excited to be expanding this successful relationship to bring even more insights to life, allowing fans to go deeper into the many ways that drivers and racing teams work together to affect success.”
“Formula 1 racing mixes physics and human performance, yielding powerful, but complex data that AWS is helping them to harness. Our existing relationship with F1 has already produced statistics that have brought fans into the race paddocks, and our study of race car aerodynamics is influencing vehicle designs for the 2022 season,” said Mike Clayville, Vice President, Worldwide Commercial Sales at AWS. “This year, we’re thrilled to extend the power of F1 data in the cloud and unlock new insights that help fans understand more of F1’s rich complexity.”
To learn more about the first 2020 F1 Insight, Car Performance Scores, please click here . For more information about AWS and its involvement with Formula 1, please visit: https://aws.amazon.com/f1/ . For additional news on how AWS is helping Formula 1 develop the next-generation race car, visit: https://aws.amazon.com/f1/news/ .
About Amazon Web Services
For 14 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. AWS offers over 175 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 76 Availability Zones (AZs) within 24 geographic regions, with announced plans for nine more Availability Zones and three more AWS Regions in Indonesia, Japan, and Spain. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com .
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews .
About Formula 1®
Formula 1® racing began in 1950 and is the world’s most prestigious motor racing competition, as well as the world’s most popular annual sporting series. The 2020 FIA Formula One World Championship™ runs from March to November and spans 22 races in 22 countries across five continents. Formula One World Championship Limited is part of Formula 1® and holds the exclusive commercial rights to the FIA Formula One World Championship™. Formula 1® is a subsidiary of Liberty Media Corporation (NASDAQ: LSXMA, LSXMB, LSXMK, BATRA, BATRK, FWONA, FWONK) attributed to the Formula One Group tracking stock. The F1 logo, F1 FORMULA 1 logo, FORMULA 1, F1, FIA FORMULA ONE WORLD CHAMPIONSHIP, GRAND PRIX, PADDOCK CLUB and related marks are trademarks of Formula One Licensing BV, a Formula 1 company. All rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200623005380/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 13:30:00 CEST | Press release
-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the location of the variant in the CFTR protein--Approximately 800 more people with CF in the US are now eligible for a CFTR modulator for the first time- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported b
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 13:30:00 CEST | Press release
A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer CasesColorectal Cancer Has Become the Leading Cause of Cancer-related Death in Adults Under Age 50 Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooper
Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press release
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom